FeaturesSignalPricingFounders
Log inGet started free
PV

Prospect Venture Partners

Venture CapitalActive

Prospect Venture Partners is a Palo Alto, California based venture capital firm with over $1B of capital under management.

Palo Alto, United StatesFounded 2007prospectventurepartners.com/
79
Investments
9
Exits
$1.2B
AUM
11.4%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Prospect Venture Partners.

Get started free

Investment Thesis & Strategy

Prospect Venture Partners invests in various stages of biotech and healthcare companies, seeking to back innovative and promising ventures with significant growth potential.

Investment Activity

Deals per year over the last 10 years

1
2001
0
2002
0
2003
2
2004
3
2005
1
2006
2
2007
2
2008
0
2009
1
2010

Portfolio Companies

Selected investments from their portfolio of 79 companies

A
Aragon Pharmaceuticals
Biotech · Series A, 2010
Active
N
Natera
Biotech · Series A, 2008
Active
T
Tetraphase Pharmaceuticals
Biotech · Series A, 2008
Active
C
Catalent Pharma Solutions
Biotech · Growth, 2007
Active
Z
Zosano Pharma
Biotech · Series A, 2007
Active
S
Symphogen
Biotech · Series A, 2006
Active
A
Achaogen
Biotech · Series A, 2005
Active
P
Portola Pharmaceuticals
Biotech · Series A, 2005
Active
A
Ambit Biosciences
Biotech · Series A, 2005
Active
M
MAP Pharmaceuticals
Biotech · Series A, 2004
Active
X
Xencor
Biotech · Series A, 2004
Active
M
Medivation
Biotech · Series A, 2001
Active

Notable Exits

CompanyTypeYearValue / Acquirer
Corvus PharmaceuticalsIPO2018
MedivationAcquisition2016$14B
PharmacyclicsAcquisition2015$21B
Avanir PharmaceuticalsAcquisition2014$3.5B
Aragon PharmaceuticalsAcquisition2013$1B
MAP PharmaceuticalsAcquisition2013
Onyx PharmaceuticalsAcquisition2013$10.4B
Portola PharmaceuticalsIPO2013
Seattle GeneticsIPO2001

Frequently Asked Questions

Prospect Venture Partners focuses on Series A, Series B, Series C+ stage investments.

Related Investors